Bacteria-Mediated Intracellular Click Reaction for Drug Enrichment and Selective Apoptosis of Drug-Resistant Tumor Cells
Source abstract
Abstract
Functionalized biocarriers that can perform bio-orthogonal reactions in tumor cells may provide solutions to overcome the efflux of the chemotherapeutic agent from drug-resistant tumor cells. Herein, we report the enrichment of therapeutic drugs in tumor cells through intracellular click reaction with functionalized bacteria. Specifically, an intracellular bioactive drug enrichment template (OPV@Escherichia coli) is constructed by combining positively charged oligo(phenylene-vinylene)-alkyne (OPV–C≡CH) with E. coli via electrostatic interaction. After the cell uptake of OPV@E. coli and Cu(II)-based complex, Cu(I) generated in situ can catalyze the bio-orthogonal click reaction to covalently anchor the azide-bearing molecules of cyanine 5 (Cy5-N3) and paclitaxel (PTX-N3) on OPV@E. coli. These molecules and their functions were retained and enriched inside the drug-resistant tumor cells A549T, which can label cells with fluorescent probes and selectively induce the apoptosis of drug-resistant tumor cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer Research and Treatments · Click Chemistry and Applications · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, P. R. China
College of Chemistry, University of Chinese Academy of Sciences, Beijing 100049, P. R. China
Funding
Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China
References (49)
Show source-provided references
1. 10.1021/acs.nanolett.8b0073710.1021/acs.nanolett.8b00737 ↗
2. 10.1021/cr900022610.1021/cr9000226 ↗
3. 10.1038/nrc159010.1038/nrc1590 ↗
4. 10.1038/nrc70610.1038/nrc706 ↗
5. 10.1002/ijc.2101310.1002/ijc.21013 ↗
6. 10.1016/j.ctrv.2012.02.01110.1016/j.ctrv.2012.02.011 ↗
7. 10.1016/j.molmed.2020.09.00710.1016/j.molmed.2020.09.007 ↗
8. 10.1021/mp200292c10.1021/mp200292c ↗
9. 10.1146/annurev.pharmtox.39.1.36110.1146/annurev.pharmtox.39.1.361 ↗
10. 10.1038/nrc280310.1038/nrc2803 ↗
11. 10.1074/jbc.272.27.1711810.1074/jbc.272.27.17118 ↗
12. 10.1038/s41419-020-03269-010.1038/s41419-020-03269-0 ↗
13. 10.1038/s41578-021-00328-610.1038/s41578-021-00328-6 ↗
14. 10.1016/j.addr.2015.10.02310.1016/j.addr.2015.10.023 ↗
15. 10.1002/anie.20190013510.1002/anie.201900135 ↗
16. 10.1002/anie.20210639210.1002/anie.202106392 ↗
17. 10.1002/adma.20170014110.1002/adma.201700141 ↗
18. 10.1021/acs.nanolett.8b0487510.1021/acs.nanolett.8b04875 ↗
19. 10.1002/adma.20170488810.1002/adma.201704888 ↗
20. 10.31635/ccschem.019.2018001510.31635/ccschem.019.20180015 ↗
21. 10.1016/j.nantod.2020.10096910.1016/j.nantod.2020.100969 ↗
22. 10.1002/anie.20180198410.1002/anie.201801984 ↗
23. 10.1002/anie.20200389510.1002/anie.202003895 ↗
24. 10.1021/acsmaterialslett.1c0035710.1021/acsmaterialslett.1c00357 ↗
25. 10.1002/adma.20120455010.1002/adma.201204550 ↗
26. 10.31635/ccschem.021.20210095710.31635/ccschem.021.202100957 ↗
27. 10.1038/nmat394910.1038/nmat3949 ↗
28. 10.1038/nrc125210.1038/nrc1252 ↗
29. 10.1038/nrc293410.1038/nrc2934 ↗
30. 10.1021/cr200263w10.1021/cr200263w ↗
31. 10.1002/anie.20161178310.1002/anie.201611783 ↗
32. 10.1038/nature1893010.1038/nature18930 ↗
33. 10.1126/science.aad132910.1126/science.aad1329 ↗
34. 10.1002/adma.20200452910.1002/adma.202004529 ↗
35. 10.1038/s41467-020-18800-210.1038/s41467-020-18800-2 ↗
36. 10.1038/s41591-019-0498-z10.1038/s41591-019-0498-z ↗
37. 10.1016/j.tips.2017.07.00110.1016/j.tips.2017.07.001 ↗
38. 10.1038/nrmicro.2017.17210.1038/nrmicro.2017.172 ↗
39. 10.1002/adma.20180827810.1002/adma.201808278 ↗
40. 10.1038/mt.2013.18310.1038/mt.2013.183 ↗
41. 10.1002/adma.20110202610.1002/adma.201102026 ↗
42. 10.1021/acsabm.0c0139510.1021/acsabm.0c01395 ↗
43. 10.1200/jco.1995.13.10.264310.1200/jco.1995.13.10.2643 ↗
44. 10.1002/j.1875-9114.1994.tb02785.x10.1002/j.1875-9114.1994.tb02785.x ↗
45. 10.1016/j.ccr.2004.09.01310.1016/j.ccr.2004.09.013 ↗
46. 10.1016/j.ica.2017.08.04310.1016/j.ica.2017.08.043 ↗
47. 10.1038/nchembio0308-14810.1038/nchembio0308-148 ↗
48. 10.1021/ja052906g10.1021/ja052906g ↗
49. 10.1016/j.ijpharm.2013.05.02710.1016/j.ijpharm.2013.05.027 ↗